Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flu-TBI 800 trial
NCT07214688Phase 2Recruiting
- Sponsor
- Hackensack Meridian Health
- Start
- Jan 2026
- Primary completion
- Jan 2032
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine, cyclophosphamide in hematologic malignancy, sponsored by Hackensack Meridian Health. Started Jan 2026; status: recruiting.
02
Drugs
fludarabinecyclophosphamide
03
Conditions
hematologic malignancy
Beyond the preview
Go deeper on NCT07214688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07214688.